Mutations in VKORC1 cause warfarin resistance and multiple coagulation factor deficiency type 2

…, K Hörtnagel, HJ Pelz, K Lappegard, E Seifried… - Nature, 2004 - nature.com
Coumarin derivatives such as warfarin represent the therapy of choice for the long-term
treatment and prevention of thromboembolic events. Coumarins target blood coagulation by …

Mesenchymal stem cells display coordinated rolling and adhesion behavior on endothelial cells

…, S Göttig, RJ Ludwig, R Bistrian, S Müller, E Seifried… - Blood, 2006 - ashpublications.org
To explore the initial steps by which transplanted mesenchymal stem cells (MSCs) interact
with the vessel wall in the course of extravasation, we studied binding of human MSCs to …

Patient blood management: recommendations from the 2018 Frankfurt Consensus Conference

…, J Volmink, JH Waters, EM Wood, E Seifried - Jama, 2019 - jamanetwork.com
Importance Blood transfusion is one of the most frequently used therapies worldwide and is
associated with benefits, risks, and costs. Objective To develop a set of evidence-based …

Treatment of patients with advanced cancer with the natural killer cell line NK-92

…, S Becker, R Esser, U Koehl, M Suttorp, E Seifried… - Cytotherapy, 2013 - Elsevier
Background aims Natural killer (NK) cells, either naive or genetically engineered, are
increasingly considered for cellular therapy of patients with malignancies. When using NK cells …

Cellular immunotherapy of malignancies using the clonal natural killer cell line NK-92

…, R Esser, D Schwabe, E Seifried - … of hematotherapy & …, 2001 - liebertpub.com
For years activated natural killer (A-NK) cells have been explored with respect to their efficacy
in anticancer therapy, but, except for some anectdotal reports, no clear clinical benefit has …

Selective inhibition of tumor growth by clonal NK cells expressing an ErbB2/HER2-specific chimeric antigen receptor

…, M Schmidt, R Schubert, K Kühlcke, E Seifried… - Molecular therapy, 2015 - cell.com
Natural killer (NK) cells are an important effector cell type for adoptive cancer immunotherapy.
Similar to T cells, NK cells can be modified to express chimeric antigen receptors (CARs) …

VKORC1 haplotypes and their impact on the inter-individual and inter-ethnical variability of oral anticoagulation

…, M Steffens, L Daugela, E Seifried… - Thrombosis and …, 2005 - thieme-connect.com
In order to elucidate the role of VCORC1 sequence variants in warfarin sensitivity, we
established a complete SNP map of the VKORC1 gene locus in 200 blood donors from Western …

Gene therapy with adeno-associated virus vector 5–human factor IX in adults with hemophilia B

…, J Schwäble, H Bonig, E Seifried… - Blood, The Journal …, 2018 - ashpublications.org
Gene therapy for hemophilia B aims to ameliorate bleeding risk and provide endogenous
factor IX (FIX) activity/synthesis through a single treatment, eliminating the requirement for FIX …

Feasibility and efficacy of routine PCR screening of blood donations for hepatitis C virus, hepatitis B virus, and HIV-1 in a blood-bank setting

WK Roth, M Weber, E Seifried - The Lancet, 1999 - thelancet.com
Background Despite sensitive antibody-based blood-donor screening, a residual risk of
transfusion-transmitted viral infections exists. Only direct monitoring by sensitive nucleic-acid …

Experience of German Red Cross blood donor services with nucleic acid testing: results of screening more than 30 million blood donations for human …

…, L Pichl, WK Roth, M Schmidt, E Seifried… - …, 2008 - Wiley Online Library
BACKGROUND: The risk of transfusion‐transmitted human immunodeficiency virus‐1 (HIV‐1),
hepatitis C virus (HCV), and hepatitis B virus (HBV) infections is predominantly …